Table 1.
Clinical trials using BCI and/or robotic-assisted rehabilitation in stroke identified from clinicaltrials.gov
Clinicaltrials.gov identifier | Intervention (s) | Duration of training | Participants enrolled (actual/ estimated) |
Primary outcome measure (s) |
Secondary outcome measure (s) | Has results posted (Y/N) |
---|---|---|---|---|---|---|
NCT00955838 | BCI-MIT-manus versus MIT-manus | 12 sessions— frequency unknown | 40 | Motricity score; FMA-UE; MAS |
Functional assessments; neuroradiological parameters |
No |
NCT01287975 | Standard OT versus BCI—haptic knob versus haptic knob |
Three times per week/6 weeks | 60 | ARAT; FMA-UE | Frenchay arm test; grip strength; modified ashworth scale; FIM; pain score |
No |
NCT01897025 | Real tDCS + MI-BCI versus sham tDCS + MI-BCI (MIT manus) |
Ten sessions— frequency unknown | 32 | FMA-UE | RMT of affected Ml; grip strength; box & block test; MRI parameters |
No |
NCT00746525 | BCI + FES training for elbow, wrist and finger coordination |
Five times per week/12 weeks | 66 | FMA-UE; AMAT; EEG; fMRI |
Strength testing; robotics testing; Wisconsin card sort; stroop; |
No |
NCT01948739 | BCI-MAHI-Exo II robotic- training | Three times per week/4 weeks | 30 | FMA-UE motor score | JTHFT; ARAT; brain volume of activation; pain and fatigue scores; grip and pinch strength; robotic motor measures of trajectory error and smoothness |
No |
NCT01724164 | Robotic arm trainer—bimanu-track. | Five times per week/4 weeks | 100 | FMA | N/A | No |
Robotic therapy versus mirror therapy versus conventional therapy versus robotic therapy + FES versus Mirror therapy + FES |
||||||
NCT01552733 | Robotic training (MIT inmotion robot) versus standard of care |
12 sessions, frequency unknown | 80 | FMA; feasibility (defined as no. of individuals completing 12 sessions) | FMA; modified rankin score; barthel Index; stroke impact scale; NIHSS; ARAT |
No |
NCT01689883 | Armeo spring UL robotic training + stochastic resonance stimulation versus Armeo spring UL robotic training + sham stimulation |
Frequency/duration unknown | 20 | Grip strength; box & block test |
Modified ashworth scale; MAL; JTHFT; FMA-UE |
No |
*NCT00075283 | Gait training with Lokomat versus conventional gait training |
Three times per week/8–10 weeks (24 sessions in total) | 50 | N/A | N/A | No |
NCT00372411 | MIT-manus robotic therapy versus intense comparison therapy versus usual care |
36 treatment sessions in total over 12 weeks (four blocks of nine sessions each for robotic therapy) |
127 | FMA-UE | Stroke Impact Scale; Wolf Motor function test; NRS for pain; Modified Ashworth scale |
Yes |
NCT01945515 | Robotic gait training (Walkbot exoskeleton) + anodal tDCS versus Robotic gait training + sham tDCS |
Five times per week/2 weeks | 34 | Functional ambulatory category score |
10-m walk test; 6-min walk test; modified rankin scale; FMA-LE; motor evoked potential |
No |
**NCT01726998 | Robot-assisted gait training with Lokomat (in addition to conventional PT) versus conventional gait training |
Daily for 4 weeks | 36 | Change in functional ambulatory category score |
N/A | No |
NCT00975156 | Lokomat gait training versus conventional PT |
Five times per week/8 weeks (total 40 sessions) | 21 | 10-m walk test | 6-min walking distance | Yes |
***NCT01994395 | Stride management assist (Honda’s walking assist device) versus Impairment based physical therapy |
18 sessions over approximately 8 weeks |
58 | 10-m walk test (change from baseline) | ABC scale; NPRS; SS-QOL; mFES; PHQ- 9; TMS; 6-min walk test (change from baseline); berg balance scale |
No |
NCT02114450 | Rbot-assisted training with H2 powered lower limb exoskeleton versus Supervised motor practice |
12 sessions over approximately 4 weeks |
60 | Change from baseline in: FMA-LE; FGA; lower limb kinematics during walking; cortical dynamics measured by EEG |
Change from baseline in: Robotic measure of performance; berg balance scale score; distance walked in 6-min walk test; timed up & go test |
No |
This study record is old and has not been updated on ClinicalTrials.gov, but appears to be published in [50]
No secondary outcome measures were indicated in the database fields, but free text in the description suggests that Motricity Index, Modified Barthel Index, FMA-LE and MRC scores for LE are likely secondary outcomes
This study did not appear in the search results for the terms specified, but is included as it pertains to the Walking Assist Device
FMA—fugl meyer assessment, UE—upper extremity, LE—lower extremity, MAL—motor activity log, MAS—motor assessment scale, ARAT—action research arm test, FIM—functional independence measure, JTHFT—jebsen taylor hand function test, NIHSS—NIH stroke scale, RMT—resting motor threshold, Ml—primary motor cortex, PT—physical therapy, NRS—numeric rating scale, AMAT—arm motor ability test, ABC—activities specific balance confidence, NPRS—numeric pain rating scale, SS-QOL—stroke-specific quality of life, mFES—modified falls efficacy scale, PHQ-9—patient health questionnaire-9, TMS—transcranial magnetic stimulation to measure corticomotor drive, FGA—Functional Gait assessment